CAPLIPOINT - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.7
| Stock Code | CAPLIPOINT | Market Cap | 12,320 Cr. | Current Price | 1,622 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 34.0 | Book Value | 243 ₹ | Dividend Yield | 0.37 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,741 ₹ | DMA 200 | 1,893 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.05 % | PAT Qtr | 87.3 Cr. | PAT Prev Qtr | 103 Cr. |
| RSI | 33.8 | MACD | -31.8 | Volume | 56,852 | Avg Vol 1Wk | 71,619 |
| Low price | 1,551 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.55 | Debt to equity | 0.00 |
| 52w Index | 8.36 % | Qtr Profit Var | 16.8 % | EPS | 47.7 ₹ | Industry PE | 27.2 |
📊 CAPLIPOINT shows moderate potential for swing trading. The RSI at 33.8 indicates oversold conditions, suggesting possible rebound. However, MACD is negative (-31.8), reflecting short-term weakness. Strong ROCE (28.6%) and ROE (22.0%) highlight operational efficiency, while debt-free status adds financial stability. Valuation is relatively high with a P/E of 34 compared to industry PE of 27.2, and PEG ratio of 1.55 suggests limited growth-adjusted value.
💡 Optimal Entry Price: Around ₹1,580–1,600, near support levels and below the 50 DMA (₹1,741).
📈 Exit Strategy (if already holding): Consider booking profits near ₹1,730–1,760, aligning with the 50 DMA resistance zone.
✅ Positive
- Strong ROCE (28.6%) and ROE (22.0%) indicate efficient capital use.
- Debt-free balance sheet reduces financial risk.
- EPS of ₹47.7 supports earnings strength.
- Quarterly profit growth of 16.8% despite slight decline in PAT.
⚠️ Limitation
- High P/E (34.0) compared to industry average (27.2).
- PEG ratio of 1.55 suggests limited growth-adjusted value.
- Dividend yield at 0.37% is low, limiting income appeal.
- Trading volume below weekly average, showing weaker momentum.
📉 Company Negative News
- No major negative news reported, but recent PAT decline from ₹103 Cr. to ₹87.3 Cr. raises caution.
📈 Company Positive News
- Strong operational efficiency with high ROCE and ROE.
- Debt-free status enhances financial stability.
- Institutional holdings remain stable with slight FII increase.
🏭 Industry
- Industry PE is 27.2, lower than CAPLIPOINT’s 34, suggesting relative overvaluation.
- Pharmaceutical sector continues to benefit from global demand and innovation trends.
🔎 Conclusion
CAPLIPOINT is a fair candidate for swing trading with entry near ₹1,580–1,600 and exit around ₹1,730–1,760. Strong fundamentals and debt-free status are positives, but high valuation and short-term weakness limit upside. Suitable for traders with moderate risk appetite looking for rebound opportunities.